China (140M diabetics), Japan (Ozempic 2021, Wegovy 2023) India: fastest-growing APAC sub-market at 19.89% CAGR GLP-1 biosimilar production and growing middle class Europe: 24.4% market share (2026)
This research is the first national-scale Epic Cosmos analysis, to our knowledge, to characterize real-world use of combined GLP-1RA therapy and MBS among adolescents and young adults with obesity, said lead author Sarah Messiah, Ph.D., M.P.H., Professor of Epidemiology and Associate Dean for Research in the Peter ODonnell Jr
Notably, no published study has specifically targeted early PsA populations, a critical gap the review identified
Tapp, H
The deep calorie deficit forces your body to burn muscle for energy, and the shrinking muscle removes the essential mechanical signal your bones need to stay dense